The Use of Topical Hemostatic Agents in Cardiothoracic Surgery

Art Bracey, Aryeh Shander, Solomon Aronson, Bradley Boucher, Domenico Calcaterra, Michael W.A. Chu, Richard Culbertson, Karim Jabr, Henrik Kehlet, Omar Lattouf, S. Chris Malaisrie, C. David Mazer, Martin M. Oberhoffer, Sherri Ozawa, Theolyn Price, Todd Rosengart, Bruce D. Spiess, Giuseppe Turchetti

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Topical hemostatic agents are used in conjunction with conventional procedures to reduce blood loss. They are often used in cardiothoracic surgery, which is particularly prone to bleeding risks. Variation in their use exists because detailed policy and practice guidelines reflecting the current medical evidence have not been developed to promote best surgical practice in this setting. To address this need, the Society for the Advancement of Blood Management convened an International Hemostatic Expert Panel. This article reviews the available literature and sets out evidence-based recommendations for the use of topical hemostatic agents in cardiothoracic surgery.

Original languageEnglish (US)
Pages (from-to)353-360
Number of pages8
JournalAnnals of Thoracic Surgery
Volume104
Issue number1
DOIs
StatePublished - Jul 1 2017

Fingerprint

Hemostatics
Practice Guidelines
Hemorrhage

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Bracey, A., Shander, A., Aronson, S., Boucher, B., Calcaterra, D., Chu, M. W. A., ... Turchetti, G. (2017). The Use of Topical Hemostatic Agents in Cardiothoracic Surgery. Annals of Thoracic Surgery, 104(1), 353-360. https://doi.org/10.1016/j.athoracsur.2017.01.096

The Use of Topical Hemostatic Agents in Cardiothoracic Surgery. / Bracey, Art; Shander, Aryeh; Aronson, Solomon; Boucher, Bradley; Calcaterra, Domenico; Chu, Michael W.A.; Culbertson, Richard; Jabr, Karim; Kehlet, Henrik; Lattouf, Omar; Malaisrie, S. Chris; Mazer, C. David; Oberhoffer, Martin M.; Ozawa, Sherri; Price, Theolyn; Rosengart, Todd; Spiess, Bruce D.; Turchetti, Giuseppe.

In: Annals of Thoracic Surgery, Vol. 104, No. 1, 01.07.2017, p. 353-360.

Research output: Contribution to journalReview article

Bracey, A, Shander, A, Aronson, S, Boucher, B, Calcaterra, D, Chu, MWA, Culbertson, R, Jabr, K, Kehlet, H, Lattouf, O, Malaisrie, SC, Mazer, CD, Oberhoffer, MM, Ozawa, S, Price, T, Rosengart, T, Spiess, BD & Turchetti, G 2017, 'The Use of Topical Hemostatic Agents in Cardiothoracic Surgery', Annals of Thoracic Surgery, vol. 104, no. 1, pp. 353-360. https://doi.org/10.1016/j.athoracsur.2017.01.096
Bracey, Art ; Shander, Aryeh ; Aronson, Solomon ; Boucher, Bradley ; Calcaterra, Domenico ; Chu, Michael W.A. ; Culbertson, Richard ; Jabr, Karim ; Kehlet, Henrik ; Lattouf, Omar ; Malaisrie, S. Chris ; Mazer, C. David ; Oberhoffer, Martin M. ; Ozawa, Sherri ; Price, Theolyn ; Rosengart, Todd ; Spiess, Bruce D. ; Turchetti, Giuseppe. / The Use of Topical Hemostatic Agents in Cardiothoracic Surgery. In: Annals of Thoracic Surgery. 2017 ; Vol. 104, No. 1. pp. 353-360.
@article{ed871fa1275c4590ae018a329c0a0a31,
title = "The Use of Topical Hemostatic Agents in Cardiothoracic Surgery",
abstract = "Topical hemostatic agents are used in conjunction with conventional procedures to reduce blood loss. They are often used in cardiothoracic surgery, which is particularly prone to bleeding risks. Variation in their use exists because detailed policy and practice guidelines reflecting the current medical evidence have not been developed to promote best surgical practice in this setting. To address this need, the Society for the Advancement of Blood Management convened an International Hemostatic Expert Panel. This article reviews the available literature and sets out evidence-based recommendations for the use of topical hemostatic agents in cardiothoracic surgery.",
author = "Art Bracey and Aryeh Shander and Solomon Aronson and Bradley Boucher and Domenico Calcaterra and Chu, {Michael W.A.} and Richard Culbertson and Karim Jabr and Henrik Kehlet and Omar Lattouf and Malaisrie, {S. Chris} and Mazer, {C. David} and Oberhoffer, {Martin M.} and Sherri Ozawa and Theolyn Price and Todd Rosengart and Spiess, {Bruce D.} and Giuseppe Turchetti",
year = "2017",
month = "7",
day = "1",
doi = "10.1016/j.athoracsur.2017.01.096",
language = "English (US)",
volume = "104",
pages = "353--360",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - The Use of Topical Hemostatic Agents in Cardiothoracic Surgery

AU - Bracey, Art

AU - Shander, Aryeh

AU - Aronson, Solomon

AU - Boucher, Bradley

AU - Calcaterra, Domenico

AU - Chu, Michael W.A.

AU - Culbertson, Richard

AU - Jabr, Karim

AU - Kehlet, Henrik

AU - Lattouf, Omar

AU - Malaisrie, S. Chris

AU - Mazer, C. David

AU - Oberhoffer, Martin M.

AU - Ozawa, Sherri

AU - Price, Theolyn

AU - Rosengart, Todd

AU - Spiess, Bruce D.

AU - Turchetti, Giuseppe

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Topical hemostatic agents are used in conjunction with conventional procedures to reduce blood loss. They are often used in cardiothoracic surgery, which is particularly prone to bleeding risks. Variation in their use exists because detailed policy and practice guidelines reflecting the current medical evidence have not been developed to promote best surgical practice in this setting. To address this need, the Society for the Advancement of Blood Management convened an International Hemostatic Expert Panel. This article reviews the available literature and sets out evidence-based recommendations for the use of topical hemostatic agents in cardiothoracic surgery.

AB - Topical hemostatic agents are used in conjunction with conventional procedures to reduce blood loss. They are often used in cardiothoracic surgery, which is particularly prone to bleeding risks. Variation in their use exists because detailed policy and practice guidelines reflecting the current medical evidence have not been developed to promote best surgical practice in this setting. To address this need, the Society for the Advancement of Blood Management convened an International Hemostatic Expert Panel. This article reviews the available literature and sets out evidence-based recommendations for the use of topical hemostatic agents in cardiothoracic surgery.

UR - http://www.scopus.com/inward/record.url?scp=85018802367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018802367&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2017.01.096

DO - 10.1016/j.athoracsur.2017.01.096

M3 - Review article

VL - 104

SP - 353

EP - 360

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 1

ER -